From compliance to culture: Lessons from a quality leader on pharma’s next imperative
In an industry governed by internal inspections, external audits, and stringent regulatory oversight, quality is often seen as a means to compliance. In this Q&A with Grace Breen, SVP, Quality, Sharp, we explore the defining moments across her 30+ year biopharma career that have shaped her understanding of what quality means for pharma organizations, including CDMOs.
